Tudor Investment Corp’s Roivant Sciences ROIV Stock Holding History

Tudor Investment Corp’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-76,262	Closed	-$944K	–	3798
2025 Q2	$859K	Buy	+76,262	New	+$827K	﹤0.01%	2253
2024 Q3	–	Sell	-50,599	Closed	-$535K	–	3043
2024 Q2	$535K	Sell	50,599 -122,916	-71%	-$1.35M	﹤0.01%	1774
2024 Q1	$1.83M	Sell	173,515 -120,000	-41%	-$1.29M	0.01%	1062
2023 Q4	$3.3M	Buy	293,515 +113,789	+63%	+$1.11M	0.03%	848
2023 Q3	$2.1M	Sell	179,726 -150,865	-46%	-$1.71M	0.02%	903
2023 Q2	$3.33M	Sell	330,591 -53,512	-14%	-$479K	0.04%	627
2023 Q1	$2.83M	Buy	384,103 +212,355	+124%	+$1.75M	0.04%	611
2022 Q4	$1.37M	Sell	171,748 -182,351	-51%	-$1.01M	0.03%	877
2022 Q3	$1.14M	Buy	354,099 +293,459	+484%	+$1.14M	0.02%	833
2022 Q2	$247K	Buy	+60,640	New	+$241K	0.01%	1689

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tudor Investment Corp's ROIV Position: Q3 2025 in Review

Tudor Investment Corp sold out of Roivant Sciences (ROIV) in Q3 2025, closing a stake of 76,262 shares — an estimated $944K sold.

Tudor Investment Corp first reported a position in ROIV in Q2 2022 and held it in 10 quarters. The position peaked at $3.33M in Q2 2023. 337 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

Tudor Investment Corp reported no remaining Roivant Sciences position as of Q3 2025 after selling out during the quarter.
Tudor Investment Corp sold 76,262 Roivant Sciences shares in Q3 2025, an estimated $944K.
Tudor Investment Corp first reported a position in Roivant Sciences in Q2 2022 and held it in 10 quarters.
Tudor Investment Corp's Roivant Sciences position peaked at $3.33M in Q2 2023.
337 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on Tudor Investment Corp's 13F filing for Q3 2025, filed 14 Nov 2025.